Peri-operative SLOG for Localized Pancreatic Cancer
Status:
Recruiting
Trial end date:
2023-08-24
Target enrollment:
Participant gender:
Summary
1. To evaluate the efficacy of neoadjuvant chemotherapy SLOG in localized pancreatic cancer
2. To evaluate the safety profile in patients with pancreatic cancer who receive
neoadjuvant SLOG
3. To collect tumor tissue and peripheral blood samples from the patients for a
comprehensive biomarker evaluation